SCHEMBL4075869

SCHEMBL4075869

COc1ccc(N2CCN(C(=O)CCCC(=O)O)CC2)c(OC)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
MAPT P10636 4/20 0.57
LMNA P02545 4/20 0.57
HPGD P15428 1/20 0.57
RECQL P46063 1/20 0.50
TSHR P16473 3/20 0.49
KDM4E B2RXH2 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.48
KMT2A Q03164 3/20 0.47
HTR7 P34969 1/20 0.47
MEN1 O00255 2/20 0.47
MAPK1 P28482 2/20 0.47
RAB9A P51151 1/20 0.46
GAA P10253 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GFER P55789 1/20 0.46
USP2 O75604 1/20 0.46
HTT P42858 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31207179 0.84 L3MBTL1 (0.67) ALDH1A1LMNATSHRKDM4ESMN1; SMN2
SCHEMBL19002655 0.84 MAPT (0.68) ALDH1A1MAPTLMNAHPGDRECQL
SCHEMBL17260627 0.83 MAPT (0.54) ALDH1A1MAPTLMNAHPGDRECQL
SCHEMBL7367526 0.81 L3MBTL1 (0.67) ALDH1A1LMNATSHRKDM4ESMN1; SMN2
SCHEMBL4073099 0.81 SMN1; SMN2 (0.71) ALDH1A1MAPTLMNATSHRKDM4E
SCHEMBL19049589 0.79 NOTUM (0.50) ALDH1A1MAPTHPGDRECQLTSHR
SCHEMBL4079335 0.79 NPC1 (0.64) ALDH1A1LMNARECQLTSHRKDM4E
SCHEMBL23467863 0.76 MTNR1B (0.54) ALDH1A1MAPTLMNARECQLTSHR
SCHEMBL19002664 0.76 TP53 (0.50) ALDH1A1MAPTLMNARECQLTSHR
SCHEMBL3768016 0.75 ALDH1A1 (0.53) ALDH1A1MAPTLMNAHPGDRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP claimed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US claimed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP disclosed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds PKD1, DDC, DPYD ALDH1A1 158/4885MAPT 1103/4885LMNA 1995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.